Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients

Ifosfamide and cisplatin cause urinary loss of carnitine, which is a fundamental molecule for energy production in mammalian cells. We investigated whether restoration of the carnitine pool might improve chemotherapy-induced fatigue in non-anaemic cancer patients. Consecutive patients with low plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Graziano, F, Bisonni, R, Catalano, V, Silva, R, Rovidati, S, Mencarini, E, Ferraro, B, Canestrari, F, Baldelli, A M, De Gaetano, A, Giordani, P, Testa, E, Lai, V
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375434/
https://www.ncbi.nlm.nih.gov/pubmed/12085175
http://dx.doi.org/10.1038/sj.bjc.6600413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375434/
https://www.ncbi.nlm.nih.gov/pubmed/12085175
http://dx.doi.org/10.1038/sj.bjc.6600413

Ejemplares similares